We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
-2.7%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$228M
AUM Growth
-$18.3M
Cap. Flow
-$19.8M
Cap. Flow %
-8.66%
Top 10 Hldgs %
58.67%
Holding
92
New
19
Increased
15
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.65M
2
PYPL icon
PayPal
PYPL
+$1.2M
3
TSM icon
TSMC
TSM
+$1.05M
4
IBB icon
iShares Biotechnology ETF
IBB
+$912K
5
GLD icon
SPDR Gold Trust
GLD
+$877K

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.26M
2
AMGN icon
Amgen
AMGN
+$2.87M
3
VZ icon
Verizon
VZ
+$2.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.03M
5
INCY icon
Incyte
INCY
+$1.78M

Sector Composition

Rank Sector Weight
1 Healthcare 35.44%
2 Miscellaneous 35.1%
3 Technology 11.59%
4 Communication Services 7.6%
5 Financials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTC icon
76
Intel
INTC
$580B
– –
-20,000
Closed -$1.03M
LIT icon
77
Global X Lithium & Battery Tech ETF
LIT
$1.49B
– –
-5,000
Closed -$422K
MS icon
78
Morgan Stanley
MS
$318B
– –
-12,500
Closed -$1.23M
MSFT icon
79
Microsoft
MSFT
$3.68T
– –
-2,500
Closed -$841K
MTNB icon
80
Matinas BioPharma
MTNB
$2.29M
– –
-3,090
Closed -$156K
NXPI icon
81
NXP Semiconductors
NXPI
$56.3B
– –
-3,500
Closed -$797K
ORCL icon
82
CALL
Oracle
ORCL
$455B
– –
-22,500
Closed -$1.96M
PARA
83
DELISTED
Paramount Global Class B
PARA
– –
-11,100
Closed -$335K
REGN icon
84
CALL
Regeneron Pharmaceuticals
REGN
$80.3B
– –
-200
Closed -$126K
VIR icon
85
Vir Biotechnology
VIR
$1.87B
– –
-20,000
Closed -$837K
VOO icon
86
PUT
Vanguard S&P 500 ETF
VOO
$1.04T
– –
-65,000
Closed -$28.4M
VZ icon
87
Verizon
VZ
$204B
– –
-50,000
Closed -$2.6M
WBA
88
DELISTED
Walgreens Boots Alliance
WBA
– –
-5,000
Closed -$261K
WBD icon
89
Warner Bros
WBD
$70.6B
– –
-15,990
Closed -$376K
XLP icon
90
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
– –
-9,000
Closed -$694K
ARNA
91
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-5,000
Closed -$465K
1 2 3
4

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, DCF Advisers held 92 positions worth $228M, down 7.4% from $247M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

DCF Advisers withdrew a net $19.8M in Q1 2022, closing 24 positions and reducing 21 holdings. Its most notable exit was Amgen, an estimated $2.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 41% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, DCF Advisers opened a new position in Meta Platforms (Facebook) worth $2.36M.

  • DCF Advisers's largest Q1 2022 buy was Meta Platforms (Facebook): 10,600 shares worth $2.36M.
  • DCF Advisers added most to SPDR Gold Trust in Q1 2022, an estimated $877K increase.
  • DCF Advisers's biggest Q1 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $6.26M.
  • DCF Advisers fully exited Amgen in Q1 2022, selling an estimated $2.87M.
  • DCF Advisers's ten largest holdings make up 59% of its $228M portfolio in Q1 2022.
  • DCF Advisers opened 19 new positions and closed 24 in Q1 2022.
  • DCF Advisers's portfolio value fell 7.4% quarter-over-quarter to $228M.

Based on DCF Advisers's 13F filing for Q1 2022, filed 13 May 2022.